Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Peak Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PKBO
Over the counter
8731
https://ignytespac.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Peak Bio Inc
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
- May 1st, 2024 12:00 pm
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
- Mar 5th, 2024 1:00 pm
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
- Jan 4th, 2024 1:00 pm
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing
- Sep 19th, 2023 8:00 pm
Insider Buying: Hoyoung Huh Acquires 47,000 Shares of Peak Bio Inc (PKBO)
- Sep 14th, 2023 5:09 am
Peak Bio, Inc. Announces Up-listing to OTCQB Market
- Aug 31st, 2023 1:35 pm
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors
- Aug 31st, 2023 12:00 pm
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market
- Aug 29th, 2023 12:00 pm
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital
- Aug 24th, 2023 8:05 pm
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting
- Aug 23rd, 2023 7:50 pm
Scroll